Cellgenmedix... A better human life.

Fast, Reliable, and cost-effective COVID-19 testing

Confirmatory Real-time reverse transcription polymerase chain reaction (rRT -PCR) test 

Unparalleled linearity of 0.9929~0.9999 (Correlation coefficient; R2) in concentrations ranging from 10^1~7 copies/ul

Limit of Detection of 10~30 copies/uL even in sputum.

US patent filed/South Korea patent filed (USPTO; 63022403)

Original sequence for all molecular targets

In the final stages of US FDA EUA approval / 510k with FDA application submitted since March 2020

European IVD-CE certification achieved (CMC/CE/2020/03072020.1)

ISO 13485 certified CGMP (Current Good Manufacturing Practice regulations) manufacturing process and quality management

New POC (Point of care) rapid antigen testing with unprecedented performance results

GoodGene COVID-19 variant kit

The GoodGene COVID-19 mutation RT-PCR kit enables multiplexing mutation hot spots in a singe tube to detect most (9) of the current COVID-19 variants of interest/concern including the “Delta variant” and “Delta plus variant”.

GoodGene COVID-19 mutation kit is versatile, can be run on a variety of different sequencers with a running time of ~2 hour (minus the nucleic acid extraction time) and LOD of 5-10 cp/uL.

GoodGene COVID-19 mutation kit may be used in the in vitro qualitative detection of COVID-19 virus variants from respiratory specimens and is the first PCR test that can differentiate Delta plus variant from delta variant in a single tube.

Variety of molecular microbiology and cancer genetics products

GG HPV and STD DNA chip
GG CTC Analysis
Stem cells and Cosmetics
GG Pharmacogenomics : Chemosensitivity Test
Immunotherapy and Cell Vaccine

Cellgenmedix and Goodgene Korea

We are a biotech company based in the United States and co-manufacturer and distributor of Goodgene, Inc, based in Seoul, South Korea which was cGMP certified by Korean FDA and ISO 13485. Good Gene, InC has been manufacturing and selling a number of molecular testing tools including PCR kits and DNA microarrays for the detection of infectious disease, cancer and guiding genomic information-based tailor-made treatment of infectious diseases and cancers for ~20 years. We have research facilities and hospitals where we can perform state of the art molecular studies and stem cell therapies and have achieved US and international patents and CE mark for a variety of our products.

Diamedi Clinic Laboratory

Cancer testing Mainstay of personalized cancer treatment cancer cells from the tissue specimen from biopsies and surgery circulating tumor cells (CTCs) from cancer patients even

Read More »